Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.294
AS - Asia 5.336
EU - Europa 4.426
SA - Sud America 873
AF - Africa 133
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.085
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.020
SG - Singapore 1.938
CN - Cina 1.268
HK - Hong Kong 790
DE - Germania 741
RU - Federazione Russa 732
BR - Brasile 679
VN - Vietnam 599
SE - Svezia 593
UA - Ucraina 541
IE - Irlanda 470
IT - Italia 454
GB - Regno Unito 221
FR - Francia 212
CA - Canada 206
IN - India 154
FI - Finlandia 152
AT - Austria 112
BD - Bangladesh 93
AR - Argentina 78
KR - Corea 61
TR - Turchia 57
ID - Indonesia 56
NL - Olanda 48
IQ - Iraq 47
ZA - Sudafrica 46
PK - Pakistan 41
MX - Messico 39
SA - Arabia Saudita 38
JP - Giappone 33
CZ - Repubblica Ceca 28
CO - Colombia 27
EC - Ecuador 27
PH - Filippine 24
PL - Polonia 24
UZ - Uzbekistan 23
ES - Italia 22
DK - Danimarca 17
EG - Egitto 17
VE - Venezuela 17
BE - Belgio 13
CL - Cile 12
MY - Malesia 11
NP - Nepal 11
PE - Perù 11
AU - Australia 10
PY - Paraguay 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
KE - Kenya 9
LB - Libano 9
NZ - Nuova Zelanda 9
AL - Albania 8
DZ - Algeria 8
KZ - Kazakistan 8
MA - Marocco 8
PS - Palestinian Territory 8
TH - Thailandia 8
UY - Uruguay 8
AZ - Azerbaigian 7
ET - Etiopia 7
TT - Trinidad e Tobago 7
CR - Costa Rica 6
IL - Israele 6
BG - Bulgaria 5
CH - Svizzera 5
IR - Iran 5
JM - Giamaica 5
PT - Portogallo 5
RO - Romania 5
GR - Grecia 4
HN - Honduras 4
MD - Moldavia 4
OM - Oman 4
SN - Senegal 4
TW - Taiwan 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
NG - Nigeria 3
PA - Panama 3
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
EU - Europa 2
LY - Libia 2
MU - Mauritius 2
MZ - Mozambico 2
NO - Norvegia 2
SC - Seychelles 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BT - Bhutan 1
Totale 22.072
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Woodbridge 1.161
Singapore 1.066
Ashburn 879
Fairfield 865
Hong Kong 785
Houston 775
Jacksonville 565
San Jose 486
Dublin 459
Chandler 456
Wilmington 366
Seattle 352
Dearborn 346
Cambridge 302
Frankfurt am Main 270
New York 242
Beijing 239
Princeton 225
Ho Chi Minh City 184
Chicago 174
The Dalles 145
Los Angeles 129
Milan 125
Santa Clara 125
Hanoi 121
Nanjing 119
Hangzhou 110
Altamura 108
Shanghai 99
Vienna 98
Lachine 97
Lauterbourg 97
Lawrence 95
Moscow 84
Dallas 71
São Paulo 63
Buffalo 58
Hefei 57
Seoul 57
Nanchang 46
Helsinki 45
Council Bluffs 41
San Diego 39
Shenyang 34
Ottawa 31
Dong Ket 30
Toronto 30
Hebei 29
Jiaxing 28
Jakarta 27
Munich 27
Rio de Janeiro 27
Orem 26
Dhaka 25
Guangzhou 25
London 25
Brno 23
Haiphong 23
Jinan 23
Andover 22
Norwalk 22
Salt Lake City 22
Tokyo 22
Tianjin 21
Changsha 20
Falls Church 20
Da Nang 19
Tashkent 19
Amsterdam 18
Warsaw 18
Jeddah 17
Montreal 17
Ningbo 17
Boardman 16
Mountain View 16
Brooklyn 15
Baghdad 14
Chennai 14
Fremont 14
Huizen 14
Phoenix 14
Belo Horizonte 13
Riyadh 13
Johannesburg 12
New Delhi 12
Redondo Beach 12
Tampa 12
Brussels 11
Columbus 11
Hải Dương 11
Kunming 11
Lahore 11
Nuremberg 11
Quito 11
Denver 10
Karachi 10
Mexico City 10
Miami 10
Rome 10
Totale 14.632
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 405
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 366
Clinical phenotypes in adult patients with bronchiectasis 312
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 305
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 305
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 304
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 296
Dyspnea in crackling lungs 293
Impact of traffic-related air pollution on pulmonary oxidative stress 292
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 288
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 281
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 280
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 275
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 263
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 260
A 61-year-old female with chronic cough and purulent sputum 258
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 256
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 253
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 249
A 13-year-old female with shortness of breath and pleuritic chest pain 245
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 240
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 239
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 238
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 237
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 236
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 235
The management of community-acquired pneumonia in the elderly 235
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 234
Hospital admission decision for patients with community-acquired pneumonia 227
Mixed community-acquired lower respiratory tract infections 225
Individualizing duration of antibiotic therapy in community-acquired pneumonia 225
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 224
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 216
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 215
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 214
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 213
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 213
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 212
Chlamydophila pneumoniae 212
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 210
Strategic targets of essential host-pathogen interactions 209
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 208
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 208
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 208
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 204
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 203
Azithromycin and lower respiratory tract infections 202
Pneumonia: how important are local epidemiology and smoking habits? 202
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 202
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 202
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 202
Compliance with anti-H1N1 vaccine among healthcare workers and general population 198
The bronchiectasis severity index. An international derivation and validation study 198
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 197
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 196
100 years of respiratory medicine: pneumonia 194
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 193
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 192
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 191
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 190
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 188
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 186
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 186
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 185
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 185
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 185
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 184
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 178
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 177
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 176
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 174
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 174
Antibiotics as immunomodulant agents in COPD 174
The role of biomarkers in low respiratory tract infections 174
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 173
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 173
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 173
Impact of exacerbations in the natural course of COPD 171
Chlamydia pneumoniae and Mycoplasma pneumoniae 170
The management of patients with community-acquired pneumonia beyond antibiotic therapy 170
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 170
Acute exacerbation of COPD: application of evidence-based guidelines 168
Clinical applications of azithromycin microspheres in respiratory tract infections 167
Management of nontuberculous mycobacterial infection in the elderly 166
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 165
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 164
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 163
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 163
Telithromycin in lower respiratory tract infections 162
Where are the acutely ill best cared for and who should look after them? 160
Healthcare-associated pneumonia: where do we go next? 157
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 156
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 156
Cardiac diseases complicating community-acquired pneumonia 156
Pneumococcal Vaccine and Patients with Pulmonary Diseases 151
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study 148
Bronchiectasis: An update 144
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 144
Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial 139
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 139
Totale 20.979
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021196 0 0 0 0 0 0 0 0 0 0 69 127
2021/20221.059 51 102 104 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.249 35 32 47 31 172 335 254 57 153 15 10 108
2024/20252.827 205 348 76 141 275 60 82 79 313 474 326 448
2025/20266.466 694 427 538 874 777 401 999 442 626 685 3 0
Totale 22.315